Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis: a Prospective Observational Study (LymphFM)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Lymphedema
Microbiota

Treatments

Other: analysis of a sample of stool

Study type

Observational

Funder types

Other

Identifiers

NCT06228937
6208

Details and patient eligibility

About

Lymphedema is a chronic and progressive disease of the lymphatic vessels which affects about 300 million people worldwide. Patients may experience recurrent soft tissue infection of the limb affected by lymphedema, in terms of erysipelas, lymphangitis or cellulitis. No previous study has ever investigated the possible role of the gut microbiota in the genesis of acute infectious/inflammatory episodes in these patients. Our hypothesis is that lymphedema patients with recurrent soft tissue infections are characterized by pro-inflammatory changes in the microbiota.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (Group A):

  • 18-85 years
  • primary or secondary, upper or lower limb lymphedema, I-II-III stage ISL
  • at least 3 episodes of soft tissue infection in an year, in the last 2 years
  • consent to participate in the study

Inclusion Criteria (Group B):

  • 18-85 years
  • primary or secondary, upper or lower limb lymphedema, stage I-II-III (ISL)
  • no episodes of soft tissue infection in the last 2 years
  • consent to participate in the study

Exclusion Criteria:

  • No compliance to perform limb compression and skin hygiene
  • Antibiotic therapy in the last 15 days
  • Diabetes mellitus
  • Immunodeficiency
  • Ongoing neoplastic pathology
  • Taking immunosuppressive drugs
  • Unavailability to follow-up for at least 24 months post-enrollment.

Trial design

60 participants in 2 patient groups

Group A
Description:
patients affected by limb lymphedema with recurrent soft tissue infections
Treatment:
Other: analysis of a sample of stool
Group B
Description:
patients affected by limb lymphedema without recurrent soft tissue infections
Treatment:
Other: analysis of a sample of stool

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems